IE000TTOOBX0 - ITRM (XNAS)

Iterum Therapeutics plc - Ordinary Share Action

1,77 USD

-2,65 % -0,05 USD 21.12.2024 01:57 - USD - NASDAQ (XNAS) - Cours et graphiques actuels sur MoneyPeak

Cours actuels de Iterum Therapeutics plc - Ordinary Share

Bourse	Ticker	Devise	Dernier échange	Cours	Variation journalière	Variation journalière %
NASDAQ	ITRM	USD	21.12.2024 01:57	1,77 USD	1,77 USD	0,0056 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	-2,74 %	0,0056 %	66,99 %	42,75 %	9,27 %	-95,56 %

Company Profile for Iterum Therapeutics plc - Ordinary Share Share

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

Company Data for Iterum Therapeutics plc - Ordinary Share Share

Name Iterum Therapeutics plc - Ordinary Share

Company Iterum Therapeutics plc

Symbol ITRM

Website https://www.iterumtx.com

Primary Exchange

NASDAQ

ISIN IE000TTOOBX0

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mr. Corey N. Fishman

Market Capitalization 20 Mio

Country Ireland

Currency USD

Employees 0,0 T

Address Fitzwilliam Court, 2 Dublin

IPO Date 2018-05-25

Ticker Symbols

Name	Symbol
NASDAQ	ITRM

More Shares

Investors who Iterum Therapeutics plc - Ordinary Share hold also have the following shares in their portfolio:

CHARLES SCHWAB 18/21 FLR Bond

EPH FIN.INT. 23/28 MTN Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Jobs Community Feedback Changelog